Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II and III data presented on vorinostat

Oct. 25, 2011

Therapy benefits children with Tay-Sachs and Sandhoff's diseases / News in Context

Oct. 25, 2011

Study finds biomarkers of metastatic disease progression in prostate cancer

Oct. 25, 2011

First-in-human AVI-6003 trial advances

Oct. 24, 2011

Phase II trials assess belinostat in bladder cancer and hepatocellular carcinoma

Oct. 24, 2011

Pazopanib activity reported in soft tissue sarcoma and urothelial cancer

Oct. 24, 2011

Study suggests montelukast improves pediatric atopic dermatitis

Oct. 24, 2011

Findings disclosed from ATON study evaluating atacicept in optic neuritis

Oct. 21, 2011

Promising 96-week data reported from phase II ocrelizumab trial in RRMS

Oct. 21, 2011

New antibacterials show activity against Gram-positive and -negative pathogens

Oct. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...